Global Neuroprotection Market Data Survey Report 2013-2025

Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.4 Scope of Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Daiichi Sankyo Company
  • 3.1.1 Company Information
  • 3.1.2 Product & Services
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.1.4 Recent Development
• 3.2 Eli Lilly and Company
  • 3.2.1 Company Information
  • 3.2.2 Product & Services
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.2.4 Recent Development
• 3.3 Allergan
  • 3.3.1 Company Information
  • 3.3.2 Product & Services
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.3.4 Recent Development
• 3.4 Dr. Reddy’s Laboratories
  • 3.4.1 Company Information
  • 3.4.2 Product & Services
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.4.4 Recent Development
• 3.5 Teva Pharmaceutical
  • 3.5.1 Company Information
  • 3.5.2 Product & Services
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.5.4 Recent Development
• 3.6 Novartis
  • 3.6.1 Company Information
  • 3.6.2 Product & Services
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.6.4 Recent Development
• 3.7 AstraZeneca
  • 3.7.1 Company Information
  • 3.7.2 Product & Services
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.7.4 Recent Development
• 3.8 Astrocyte Pharmaceuticals
  • 3.8.1 Company Information
  • 3.8.2 Product & Services
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.8.4 Recent Development
• 3.9 F. Hoffmann-La Roche
  • 3.9.1 Company Information
  • 3.9.2 Product & Services
  • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.10 Biogen
  • 3.10.1 Company Information
  • 3.10.2 Product & Services
  • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

• 4.1 Prevention
  • 4.1.1 Overview
  • 4.1.2 Prevention Market Size and Forecast
• 4.2 Treatment
  • 4.2.1 Overview
  • 4.2.2 Treatment Market Size and Forecast

5 Market by Type

5.By Free Radical Trapping Agents (Antioxidants)

• 5.1 Free Radical Trapping Agents (Antioxidants)
  • 5.1.1 Overview
  • 5.1.2 Free Radical Trapping Agents (Antioxidants) Market Size and Forecast
• 5.2 Glutamate Antagonists (Anti-Excitotoxic Agents)
  • 5.2.1 Overview
  • 5.2.2 Glutamate Antagonists (Anti-Excitotoxic Agents) Market Size and Forecast
• 5.3 Apoptosis Inhibitors
  • 5.3.1 Overview
  • 5.3.2 Apoptosis Inhibitors Market Size and Forecast
• 5.4 Anti-inflammatory Agents
  • 5.4.1 Overview
  • 5.4.2 Anti-inflammatory Agents Market Size and Forecast
• 5.5 Neurotrophic Factors (NTFs)
  • 5.5.1 Overview
  • 5.5.2 Neurotrophic Factors (NTFs) Market Size and Forecast
• 5.6 Metal Ion Chelators
  • 5.6.1 Overview
  • 5.6.2 Metal Ion Chelators Market Size and Forecast
• 5.7 Stimulants
  • 5.7.1 Overview
  • 5.7.2 Stimulants Market Size and Forecast
• 5.8 Others
  • 5.8.1 Overview
  • 5.8.2 Others Market Size and Forecast

6 Price Overview

• 6.1 Price by Manufacturers
• 6.2 Price by Application
• 6.3 Price by Type

7 Conclusion